Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration
Simvastatin is among the most commonly used prescription medications for cholesterol reduction and the most common statin-related adverse drug reaction is skeletal muscle toxicity. Multiple factors have been shown to influence simvastatin-induced myopathy. In addition to age, gender, ethnicity, gene...
Saved in:
Main Authors: | Nicolas De Schryver, Xavier Wittebole, Peter Van den Bergh, Vincent Haufroid, Eric Goffin, Philippe Hantson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2015/761393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
by: Nicolas De Schryver, et al.
Published: (2019-01-01) -
The protective effect of coadministration of coenzyme Q10 and vitamin E on myopathy induced by simvastatin in rats
by: Omar Ammar Hashim, et al.
Published: (2025-06-01) -
Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature
by: Dimitrios Patoulias, et al.
Published: (2017-01-01) -
S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine
by: Jamshed Dalal, et al.
Published: (2018-01-01) -
Poststernotomy Osteomyelitis Presenting with Severe Sepsis and Rhabdomyolysis
by: Eugene M. Tan, et al.
Published: (2016-01-01)